Previous Page  17 / 26 Next Page
Information
Show Menu
Previous Page 17 / 26 Next Page
Page Background

Notes:

Page 89

Dementia 2016

September 29-October 01, 2016

Volume 6 Issue 5(Suppl)

J Alzheimers Dis Parkinsonism 2016

ISSN:2161-0460 JADP, an open access journal

conferenceseries

.com

September 29-October 01, 2016 London, UK

5

th

International Conference on

Alzheimer’s Disease & Dementia

Zhongxiao Wan et al., J Alzheimers Dis Parkinsonism 2016, 6:5(Suppl)

http://dx.doi.org/10.4172/2161-0460.C1.022

The combination of 1α,25dihydroxyvitaminD3 with resveratrol prevents endoplasmic reticulum

stress-mediated neuronal degeneration by improving insulin signaling and inhibiting tau

hyperphosphorylation in SH-SY5Y cells

Zhongxiao Wan, Jinbo Cheng

and

Liqiang Qin

Soochow University, China

E

ndoplasmic reticulum stress (ER stress) is a critical factor involved in the pathogenesis of AD. Vitamin D and resveratrol

are two nutritional factors that have reported neuroprotective effects, and findings from cellular model suggest that

resveratrol could potentiate vitamin D’s effects. We aimed to determine the effects of vitamin D & resveratrol on ER stress

mediated neurodegeneration and whether synergistic effects existed. Tunicamycin (2μM) was utilized to induce ER stress in

SH-SY5Y cells, cells were then incubated with vitamin D (10

-7

, 10

-8

and 10

-9

M) and resveratrol (25μM). The combination of

vitamin D & resveratrol completely reversed tunicamycin induced cytotoxicity in SH-SY5Y cells, as well as elevation in ER

stress markers (i.e.GRP78, p-eIF2α and CHOP), insulin signaling disruption (i.e. elevation in p-IRS-1serine307 and reduction

in p-Akt serine473) and tau phosphorylation (i.e. reduction in p-GSK3βserine9, and elevation in p-Tau serine396 &404).

Further studies are required to clarify whether the observed synergistic effects in the present study would also existed

in vivo

,

this will lay scientific foundation whether the combination of vitamin D with resveratrol might be an effective maneuver in the

prevention and treatment of AD in human subjects.

Biography

Zhongxiao Wan has completed her PhD at the age of 29 years from University of Alberta and postdoctoral studies from University of British Columbia. She is now

working at Soochow University as a research fellow. She has published approximately 16 papers in reputed journals in obesity and Alzheimer's disease related

fields.

zhxwan@suda.edu.cn